In this study, the cardiovascular safety of the selective V1A receptor agonist selepressin [12–14] and AVP was investigated in comparison with that of the septic shock standard of care NE in a well-established rabbit model of early-stage atherosclerosis. Here, AVP is linked to atherosclerosis.